CHIMERNA (2025-2029)ERA4HEALTH under the NANOTECMEC

Introducing CHIMERNA, a collaborative project supported by ERA4HEALTH under the NANOTECMEC call. This initiative brings together academic and clinical researchers from three European countries to work toward a shared goal: developing a Hydrogel Immunomodulatory Therapy to tackle the complexities of colorectal cancer.

At its core, CHIMERNA focuses on a subcutaneously implantable hydrogel that provides controlled release of immune cell-attracting agents and precise, targeted mRNA polymeric nanomedicines. The aim? To enable immune cells within the patient to respond more effectively to cancer.

See all about this project on the CHIMERNA website